内部人交易记录
其他基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Mulay James. Director active across 1 company, notably CG Oncology, Inc.. In total, 18 disclosures have been logged. Split: 0 buy · 7 sells. Total volume traded: €3.5m. Activity tracked since 5 September 2025. The latest transaction was disclosed on 10 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mulay James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
24,165 股@ US$75.16Common StockSEC:0001193125-26-303188:1
24,165 股@ US$26.63Common StockSEC:0001193125-26-303188:0
654 股Common StockSEC:0001684531-26-000002:0
654 股Common StockSEC:0001684531-26-000002:1
1,310 股Common StockSEC:0001684531-26-000002:2
1,310 股Common StockSEC:0001684531-26-000002:3
15,600 股@ US$36.630.0089% mcap19.3% 占其流量Common StockSEC:0001193125-26-164013:0
15,600 股@ US$73.010.018% mcap38.4% 占其流量Common StockSEC:0001193125-26-164013:1
654 股@ US$3.720.1% 占其流量Common StockSEC:0001193125-26-110831:0
654 股@ US$3.720.2% 占其流量Common StockSEC:0001193125-26-011756:0
654 股@ US$44.162.3% 占其流量Common StockSEC:0001193125-26-011756:1
10,491 股@ US$12.5910.7% 占其流量Common StockSEC:0001193125-26-011756:2
10,491 股@ US$52.9944.9% 占其流量Common StockSEC:0001193125-26-011756:3
5,903 股@ US$3.720.7% 占其流量Common StockSEC:0001193125-25-237104:0
12,755 股@ US$1.821.9% 占其流量Common StockSEC:0001193125-25-225133:0
12,755 股@ US$39.1940.1% 占其流量Common StockSEC:0001193125-25-225133:1
19,112 股@ US$1.821.2% 占其流量Common StockSEC:0001193125-25-210015:0
27,015 股@ US$0.600.5% 占其流量Common StockSEC:0000950170-25-113556:0
About Mulay James
Mulay James is a director of CG Oncology, Inc. Across 10 total filings, the 10 sampled filings, from 2025-09-30 to 2026-06-16, show €0 of purchases and €927727 of sales, with option exercise as the most frequent transaction nature.